NORTHWEST BIOTHERAPEUTICS

Company snapshot

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing c

• 33 active pipeline program(s) linked via ClinicalTrials.gov.
• 595 US patent(s) indexed to this assignee profile.
• 33 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for NORTHWEST BIOTHERAPEUTICS. Not investment advice.

• Peer + 0 momentum

  George Institute for

  TA overlap score 40

• Peer + 0 momentum

  Peking University Biologics

  TA overlap score 33

• Peer + 0 momentum

  Telix Innovations

  TA overlap score 25.4

• Peer + 0 momentum

  ME Therapeutics

  TA overlap score 22.6

Recent activity

Latest pipeline, patent, and corporate events for NORTHWEST BIOTHERAPEUTICS.

1. Jun 8, 2026 Clinical update

   PRODIGE 107-ENGIC01-COLOSOTO — Phase 2

2. Jun 8, 2026 Clinical update

   Specific Carbohydrate Diet — Unknown

3. Jun 8, 2026 Clinical update

   Mifepristone — Approved

4. Jun 8, 2026 Clinical update

   Leuprolide or goserelin — Phase 2

5. Jun 8, 2026 Clinical update

   Ketamine Hydrochloride — Approved

View all clinical trial activity →

• What is NORTHWEST BIOTHERAPEUTICS?

  NORTHWEST BIOTHERAPEUTICS is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker NWBO. Primary therapeutic focus areas include Infertility, Ovarian Cancer, Environmental Exposure, Colorectal Carcinoma, Giant Cell Glioblastoma. NovaPharmaNews links

• Is NORTHWEST BIOTHERAPEUTICS publicly traded?

  Yes. NORTHWEST BIOTHERAPEUTICS is listed with ticker NWBO on NYSE per SEC EDGAR records linked on this profile.

• What drugs does NORTHWEST BIOTHERAPEUTICS develop or market?

  We link 40 drug profile(s) where NORTHWEST BIOTHERAPEUTICS is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/northwest-biotherapeutics-inc#company-drugs.

• What are the latest developments for NORTHWEST BIOTHERAPEUTICS?

  In the last 12 months our linked public records show 33 trial program update(s) and 20 US patent grant(s) tied to this profile.

• What therapeutic areas does NORTHWEST BIOTHERAPEUTICS focus on?

  NORTHWEST BIOTHERAPEUTICS focuses on Infertility, Ovarian Cancer, Environmental Exposure based on our analysis of their pipeline programs and drug development activities.